Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Announcing a new article publication for BIO Integration journal.   Diabetes, a common metabolic condition, poses a substantial health burden worldwide. To revolutionize diabetes management, enhance ...

“Glucagon-Like Peptide-1 Receptor: Mechanisms and Advances in Therapy.” Signal Transduction Targeted Ther. (Sept. 2024). DOI: 10.1038/s41392-024-01931-z. A collaboration between C&EN and Andy ...

Josh Gad says he's taking 'life-changing' GLP-1 medication for weight loss but admits that it can't replace having a healthy ...

Liraglutide, a GLP-1 receptor agonist, has been shown to effectively lower glucagon levels and promote ... and insulin signaling pathways. Despite being in early research stages, bile acid ...

Glucagon-Like Peptide-2 (GLP ... factors can influence the expression of GLP-2 receptors, suggesting that metabolic states can modulate GLP-2 signaling in the central nervous system[5].

The soaring demand for antidiabetic and weight-loss drugs has lured in many biotech and big Pharma companies. Onto this ...

and what this does is it takes away that signal,” Gad said of the medication. GLP-1 is short for glucagon-like peptide-1 receptor agonists, which work in the brain to impact satiety. Popular ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.